What this guide covers
How vigilance works today
Under the MDR, manufacturers report serious incidents and field safety corrective actions to the competent authority in each country concerned. Until the vigilance module is live, that happens nationally, using each authority's own process. Field safety notices are published the same way: the HPRA publishes Irish ones, BfArM German ones, and so on.
For a manufacturer, that means reporting the same action several times. For anyone monitoring the market, it means checking each country separately to find out what happened to a similar device elsewhere in Europe.
What the module covers
The vigilance and post-market surveillance module is where the MDR's vigilance reporting is meant to happen once it's live. It covers:
- Manufacturer reports of serious incidents.
- Field safety corrective actions and the field safety notices that go with them.
- Trend reports and periodic summary reports.
- PSURs for Class III and implantable devices, which are submitted to the notified body through EUDAMED.
- The authorities' own assessments and coordination of incidents.
For manufacturers, the biggest practical change is reporting once, centrally, instead of to each authority separately.
What will be public
Not all of it. Most incident reports and assessments will only be visible to competent authorities, notified bodies and the Commission. But the MDR requires field safety notices to be made publicly available through EUDAMED.
That's the part that matters for monitoring. For the first time, field safety notices from across the EU should be in one public place, searchable by device and manufacturer. Spotting a problem with a similar device in another member state will no longer depend on someone checking that country's website.
When it is likely to arrive
Under Regulation (EU) 2024/1860, each EUDAMED module becomes mandatory six months after the Commission publishes a notice in the Official Journal confirming that it works. That's how the first four modules became mandatory on 28 May 2026, six months after a decision published in November 2025.
No notice has been published for the vigilance module yet. Forecasts from consultancies and notified bodies mostly point to a notice in late 2026 or during 2027, with mandatory use six months after that. Treat any date as an estimate until the notice appears. When it does, you'll have six months.
How to prepare
There's useful work you can do before a date is set:
- Make sure your actor registration and SRN are in order. You'll need them to report.
- Map your current incident reporting process, country by country, and decide who will report through EUDAMED once it's live.
- Check that your devices are registered, legacy devices included. Reports will need to point to a registered device. Our legacy device guide covers the November 2026 deadline.
- Decide who will watch the public field safety notices for similar devices, and how often.
That last point is the one most teams leave until later, and it's the one that pays off soonest.
Until then
Until the module is live, EU safety information stays spread across national authorities. MedFortis brings together recalls and safety notices from the FDA, MHRA, Health Canada and Swissmedic, and from national authorities such as the HPRA and BfArM, alongside each device's EUDAMED registration status. That gives you a single view of what's being published about your devices and similar ones today, without waiting for the vigilance module.
See what's being published about your devices
Book a free 30-minute demo. We'll run MedFortis on your device lines and show you their safety notices and EUDAMED status, live.
Book a Demo →Key takeaways
- EU vigilance reporting and field safety notices are still handled country by country.
- The EUDAMED vigilance module will centralise incident reports, FSCAs, trend reports and some PSURs.
- Field safety notices will be public through EUDAMED, which makes EU-wide monitoring much easier.
- The module becomes mandatory six months after a Commission notice. None has been published yet, and most forecasts point to 2027.